Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Deals & Financings

Immuno Cure Acquires Partner Teresa Healthcare, an Electroporation Company
Biocytogen and FineImmune Partner on Cell Therapies Targeting Intracellular Antigens
Arnatar Biomedical Raises $15 Million in Seed Round for RNAi Therapies
Apollomics, a US-China Biopharma, will Merge with SPAC to List on NASDAQ Exchange
Lepu Medical, a Medical Device Company, Raises $224 Million by Listing on Swiss Exchange
ChinaBio Event
Beijing and Digital
November 8-11, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022